top of page
.png)
Eyes on Pharma
Check-out What Intel Caught our Eye
Jana Chisholm
Dec 11, 202416 min read
Eyes on 3Q24 Financial Results
We've highlighted a few firms: Lilly, AbbVie, Pfizer, Novo Nordisk, BMS, Roche, Novartis, Merck, AstraZeneca, GSK, Viatris, Teva, and Amgen.
Jana Chisholm
Nov 17, 20244 min read
Eyes on Sanofi, Regeneron, Novo Nordisk, and Pfizer
We've had Eyes On some of the recent deals, results, and investor actions. Check out the happenings at Sanofi/Opella, Pfizer, Regeneron, and
Jana Chisholm
Oct 5, 20246 min read
Eyes on BMS, Pfizer, & Amgen
Eye's on the Amgen data releases for gMG & Atopic Dermatitis, the BMS approval of Cobenfy for schizophrenia, and Pfizer's Oxbryta recall...
Jana Chisholm
Sep 20, 20245 min read
Eyes on BioPharma Headlines
This month, we've had Eyes on investment trends, strategic restructuring, and FDA decisions. Fall seems to be gearing up, and we can't wait
Jana Chisholm
Mar 24, 20244 min read
Eyes on Current Events - Deals, Approvals & Operations
We've been trying to keep up with current events - here's some of what we've hay Eyes On this week.
Jana Chisholm
Dec 1, 20233 min read
Eyes on Clinical Trial Data, Supply Upgrades, and Patent Litigation
The news this week was full of "Ups-n-Downs." We've noted a few here and know there were more surprises with clinical data results, M&A, and
jroele
Apr 4, 20222 min read
PharmaTell Studio Upgrades
We are excited to share the latest upgrades to PharmaTell Studio making it even easier for you to keep your eyes on you & your competition.
Robin Bateman
Mar 20, 20222 min read
Gene Therapy Guidance
This week, the team had Eyes on the new draft guidance from the US FDA on Gene Therapy Products Incorporating Genome Editing.
Robin Bateman
Mar 13, 20221 min read
Industry Intel
Today we’ll share some of the types of reports available that can help you keep your Eyes on Pharma Sectors.
Robin Bateman
Mar 6, 20222 min read
Tracking Data
We found several different types of intel so we thought we would share some with you – and tips on how to find it.
Robin Bateman
Feb 27, 20222 min read
Opioids, SPACs, Top 10 Lists, and more Results
Check out the latest on some of the Opioid Litigation, SPACS, and yes two Top 10 Lists!
Robin Bateman
Feb 22, 20222 min read
R&D Trends, ASCO-GU, & Earnings
The Eyes on Pharma team was caught up in reviewing global R&D trends and following the updates from ASCO-GU ...
bottom of page